Bravelle is a remedy that serves to treat female infertility. This remedy is indicated for the treatment of cases where there is no ovulation, Polycystic Ovary Syndrome and is used in Assisted Reproduction techniques.
This medication has in its composition the hormone FSH, a hormone naturally produced by the body that is responsible for stimulating the development of follicles in the ovaries and the production of sex hormones.
Price
The price of Bravelle varies between 100 and 180 reais, and can be purchased at pharmacies or online stores.
How to take
The doses to be taken of Bravelle should be indicated by the doctor who accompanies the treatment, it is generally indicated to start the treatment in the first 7 days of the menstrual cycle, with a dose of 75 mg per day. Generally, treatment should last a minimum of 7 days.
To give the Bravelle injection, you must follow the instructions described below:
- Start by opening the diluent ampoule and with the aid of a sterile syringe you should aspirate the entire contents; Then, transfer the contents of the syringe to the powder vial provided in the Bravelle pack. Shake the bottle slightly and the powder is expected to dissolve within 2 minutes. To give the injection, you must pull a piece of skin until it forms a pocket between your fingers, and then you must insert the needle in a rapid movement at a 90 degree angle. After inserting the needle, you must press the plunger to inject the solution. Finally, remove the syringe and press the injection site with some alcohol-soaked cotton to stop the bleeding.
Side effects
Some of Bravelle's side effects may include headache, abdominal pain, urinary tract infection, inflammation of the throat and nose, redness, nausea, vomiting, bloating and abdominal discomfort, diarrhea, constipation, muscle contractions, vaginal bleeding, pelvic pain, vaginal discharge or pain, redness or swelling at the injection site.
Contraindications
Bravelle is contraindicated for pregnant or nursing women, patients with tumors in the uterus, ovaries, sinuses, pituitary gland or hypothalamus, blockage of the uterine tubes or other physical defects of the uterus or other sexual organs, vaginal bleeding of unknown cause, thyroid problems or adrenal glands, primary ovarian failure, premature menopause, elevated prolactin levels, patients with ovarian cysts or increased ovary size due to polycystic ovary disease and for patients with an allergy to Urofolitropine or any of the components of the formula.
